Delivery Order SPE2DB20D2104-SPE2DB21FU01L
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.00 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, 30ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.05 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The federal contract award SPE2DB22D1106|SPE2DB25FDPM8 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.60 firm fixed price delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, 30 ML. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.72, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award, with ID SPE2DB20D2001|SPE2DB23FM34M, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,084.96 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray in 30 mL containers. The contract has an ultimate completion date of January 4, 2023 and was awarded on January 3, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp, as a major...
- This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPTQ2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,322.40 firm fixed price delivery order is for the supply of 4566316369 - Azelastine 0.1% (137 MCG) Spray, 30 ML. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
- The Defense Logistics Agency awarded a $3,541.53 delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 MCG) spray in 30ML quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 mcg) spray in a 30 ml format, with a ceiling value of $2,352.57. This non-competitive, firm fixed-price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a pharmaceutical supply transaction under DLA's medical procurement operations. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in 30 mL containers, with a ceiling value of $3,225.60. This non-competitive delivery order represents a firm fixed-price procurement and is scheduled for completion by August 21, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FU01LDelivery Order
This federal contract award, valued at $1,245.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Azelastine 0.1% (137 MCG) spray medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. By leveraging its extensive supply chain and distribution capabilities, Amerisourcebergen plays a critical role in delivering essential pharmaceutical and medical commodities to the Department of Defense and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/20/21 |